Any other medical condition, which in the opinion of the Investigator, places the subject at an unacceptably high risk for toxicities.
The patient has any medical condition which in the opinion of the Investigator places the patient at an unacceptably high risk for toxicities.
Subjects may not receive ABBV- in combination with erlotinib or nivolumab if they have any medical condition which in the opinion of the Investigator places the subject at an unacceptably high risk for toxicities from the combination.
Any medical condition which in the opinion of the study investigator places the subject at an unacceptably high risk for toxicities
Clinically significant and uncontrolled major medical condition(s) including but not limited to:\r\n* Active uncontrolled infection\r\n* Symptomatic congestive heart failure\r\n* Unstable angina pectoris or cardiac arrhythmia\r\n* Psychiatric illness/social situation that would limit compliance with study requirements\r\n* Any medical condition, which in the opinion of the study investigator places the subject at an unacceptably high risk for toxicities
Any condition presenting an unacceptably high anesthetic or surgical risk
Participant has any medical condition which in the opinion of the investigator places the participant at an unacceptably high risk for toxicities.
Clinically significant and uncontrolled major medical condition(s) including but not limited to:\r\n* Active uncontrolled infection\r\n* Symptomatic congestive heart failure\r\n* Unstable angina pectoris or cardiac arrhythmia\r\n* Psychiatric illness/social situation that would limit compliance with study requirements\r\n* Any medical condition, which in the opinion of the study investigator places the subject at an unacceptably high risk for toxicities
Clinically significant and uncontrolled major medical condition(s) that places the\n             subject at an unacceptably high risk for toxicities. These include, but are not\n             limited to: active infections, symptomatic pulmonary disease, inadequate pulmonary\n             function, seizure disorder, psychiatric illness.
The patient has any medical condition which in the opinion of the investigator places the patient at an unacceptably high risk for toxicities.
The patient has any medical condition which, in the opinion of the Investigator, places the patient at an unacceptably high risk for toxicities.
Clinically significant and uncontrolled major medical condition(s) including but not limited to:\r\n* Active uncontrolled infection\r\n* Symptomatic congestive heart failure\r\n* Unstable angina pectoris or cardiac arrhythmia\r\n* Psychiatric illness/social situation that would limit compliance with study requirements\r\n* Any medical condition, which in the opinion of the study investigator places the subject at an unacceptably high risk for toxicities
Any medical condition which in the opinion of the investigator places the participant at an unacceptably high risk for toxicities.
Clinically significant and uncontrolled major medical condition(s) including but not limited to:\r\n* Active uncontrolled infection\r\n* Symptomatic congestive heart failure\r\n* Unstable angina pectoris or cardiac arrhythmia\r\n* Psychiatric illness/social situation that would limit compliance with study requirements\r\n* Any medical condition, which in the opinion of the study investigator places the subject at an unacceptably high risk for toxicities
Any medical condition, which in the opinion of the study Investigator, places the participant at an unacceptably high risk for toxicities
Any medical condition, which in the opinion of the study investigator, places the subject at an unacceptably high risk for toxicities;
The patient has any medical condition which in the opinion of the Investigator places the patient at an unacceptably high risk for toxicities.
Subject has any medical condition which in the opinion of the investigator places the subject at an unacceptably high risk for toxicities.
Clinically significant and uncontrolled major medical conditions including but not limited to: active uncontrolled infection, psychiatric illness/ social situation that would limit compliance with study requirements; any medical condition, which in the opinion of the study investigator places the subject at an unacceptably high risk for toxicities
